Chemistry:CDPPB

From HandWiki
Revision as of 02:57, 9 March 2024 by WikiEditor (talk | contribs) (change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
CDPPB
CDPPB Structure.svg
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
Chemical and physical data
FormulaC23H18N4O
Molar mass366.424 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

CDPPB is a drug used in scientific research which acts as a positive allosteric modulator selective for the metabotropic glutamate receptor subtype mGluR5.[1][2][3] It has antipsychotic effects in animal models,[4] and mGluR5 modulators are under investigation as potential drugs for the treatment of schizophrenia,[5] as well as other applications.[6][7]

References

  1. "Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo". Journal of Medicinal Chemistry 47 (24): 5825–8. November 2004. doi:10.1021/jm049400d. PMID 15537338. 
  2. "Substituent effects of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides on positive allosteric modulation of the metabotropic glutamate-5 receptor in rat cortical astrocytes". Journal of Medicinal Chemistry 49 (11): 3332–44. June 2006. doi:10.1021/jm051252j. PMID 16722652. 
  3. "Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses". Molecular Pharmacology 71 (5): 1389–98. May 2007. doi:10.1124/mol.106.032425. PMID 17303702. 
  4. "A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models". The Journal of Pharmacology and Experimental Therapeutics 313 (1): 199–206. April 2005. doi:10.1124/jpet.104.079244. PMID 15608073. 
  5. "Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia". Current Topics in Medicinal Chemistry 6 (8): 771–85. 2006. doi:10.2174/156802606777057599. PMID 16719816. 
  6. "Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex". Biological Psychiatry 62 (7): 739–46. October 2007. doi:10.1016/j.biopsych.2006.12.003. PMID 17511968. 
  7. "Positive allosteric modulation of mGluR5 receptors facilitates extinction of a cocaine contextual memory". Biological Psychiatry 65 (8): 717–20. April 2009. doi:10.1016/j.biopsych.2008.11.001. PMID 19100966.